Web Results

en.wikipedia.org/wiki/Miglustat

Miglustat (OGT 918, N-butyl-deoxynojirimycin) is a drug developed by Oxford GlycoSciences and marketed by Actelion and is used primarily to treat type I ...

www.drugbank.ca/drugs/DB00419

Miglustat is a drug used to treat Gaucher disease. It inhibits the enzyme ... Miglustat was first developed as an anti-HIV agent in the 1990s. However, clinical  ...

pubchem.ncbi.nlm.nih.gov/compound/Miglustat

Miglustat is a synthetic, N-alkylated imino analogue of D-glucose. Miglustat competitively and reversibly binds to and inhibits the activity of UDP-glucose ...

medlineplus.gov/druginfo/meds/a604015.html

Apr 15, 2016 ... Miglustat: learn about side effects, dosage, special precautions, and more on MedlinePlus.

www.rxlist.com/zavesca-drug.htm

Zavesca (miglustat capsules, 100 mg) is an inhibitor of the enzyme glucosylceramide synthase, which is a glucosyl transferase enzyme responsible for the first ...

www1.actelion.com/documents/en-rebranded/our-products/zavesca-smpc.pdf

Pharmacokinetic data indicate increased systemic exposure to miglustat in patients with renal impairment. In patients with an adjusted creatinine clearance of ...

www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000435/human_med_001171.jsp&mid=WC0b01ac058001d124

Home · Find medicine; Human medicines. Zavesca. miglustat. Email; Print; Help. Share. About; Authorisation details; Product information; Assessment history ...

www.sciencedirect.com/topics/neuroscience/miglustat

Miglustat. Miglustat is an inhibitor of glucosylceramide synthase that was launched as an oral treatment for mild to moderate type I Gaucher's disease in adult ...